These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 2219668

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Escherichia coli cytotoxins and enterotoxins.
    Gyles CL.
    Can J Microbiol; 1992 Jul; 38(7):734-46. PubMed ID: 1393838
    [Abstract] [Full Text] [Related]

  • 3. Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine.
    Weinstein DL, Jackson MP, Samuel JE, Holmes RK, O'Brien AD.
    J Bacteriol; 1988 Sep; 170(9):4223-30. PubMed ID: 3045088
    [Abstract] [Full Text] [Related]

  • 4. Effects of Escherichia coli Shiga-like toxins (verotoxins) in pigs.
    Gannon VP, Gyles CL, Wilcock BP.
    Can J Vet Res; 1989 Jul; 53(3):306-12. PubMed ID: 2670167
    [Abstract] [Full Text] [Related]

  • 5. Variants of Shiga-like toxin II constitute a major toxin component in Escherichia coli O157 strains from patients with haemolytic uraemic syndrome.
    Rüssmann H, Schmidt H, Heesemann J, Caprioli A, Karch H.
    J Med Microbiol; 1994 May; 40(5):338-43. PubMed ID: 7909850
    [Abstract] [Full Text] [Related]

  • 6. Characterization of Escherichia coli strains isolated from pigs with edema disease.
    Wasteson Y, Lund A, Olsvik O.
    Vet Microbiol; 1992 Feb; 30(2-3):179-90. PubMed ID: 1557896
    [Abstract] [Full Text] [Related]

  • 7. Transcription of the Shiga-like toxin type II and Shiga-like toxin type II variant operons of Escherichia coli.
    Sung LM, Jackson MP, O'Brien AD, Holmes RK.
    J Bacteriol; 1990 Nov; 172(11):6386-95. PubMed ID: 2228965
    [Abstract] [Full Text] [Related]

  • 8. Hybridization of Escherichia coli producing Shiga-like toxin I, Shiga-like toxin II, and a variant of Shiga-like toxin II with synthetic oligonucleotide probes.
    Brown JE, Sethabutr O, Jackson MP, Lolekha S, Echeverria P.
    Infect Immun; 1989 Sep; 57(9):2811-4. PubMed ID: 2668189
    [Abstract] [Full Text] [Related]

  • 9. Physicochemical and biological properties of purified Escherichia coli Shiga-like toxin II variant.
    MacLeod DL, Gyles CL, Valdivieso-Garcia A, Clarke RC.
    Infect Immun; 1991 Apr; 59(4):1300-6. PubMed ID: 2004812
    [Abstract] [Full Text] [Related]

  • 10. Immunization of pigs with a purified Shiga-like toxin II variant toxoid.
    MacLeod DL, Gyles CL.
    Vet Microbiol; 1991 Nov; 29(3-4):309-18. PubMed ID: 1837635
    [Abstract] [Full Text] [Related]

  • 11. An enzymatic mutant of Shiga-like toxin II variant is a vaccine candidate for edema disease of swine.
    Gordon VM, Whipp SC, Moon HW, O'Brien AD, Samuel JE.
    Infect Immun; 1992 Feb; 60(2):485-90. PubMed ID: 1730480
    [Abstract] [Full Text] [Related]

  • 12. In vivo formation of hybrid toxins comprising Shiga toxin and the Shiga-like toxins and role of the B subunit in localization and cytotoxic activity.
    Weinstein DL, Jackson MP, Perera LP, Holmes RK, O'Brien AD.
    Infect Immun; 1989 Dec; 57(12):3743-50. PubMed ID: 2807546
    [Abstract] [Full Text] [Related]

  • 13. The specific activities of Shiga-like toxin type II (SLT-II) and SLT-II-related toxins of enterohemorrhagic Escherichia coli differ when measured by Vero cell cytotoxicity but not by mouse lethality.
    Lindgren SW, Samuel JE, Schmitt CK, O'Brien AD.
    Infect Immun; 1994 Feb; 62(2):623-31. PubMed ID: 8300218
    [Abstract] [Full Text] [Related]

  • 14. Purification and some properties of a Vero toxin 2 (Shiga-like toxin II) variant (SLT-IIva) of Escherichia coli isolated from infantile diarrhea.
    Ohmura M, Cao C, Karasawa T, Okuda J, Kurazono H, Gannon VP, Gyles CL, Takeda Y.
    Microb Pathog; 1993 Nov; 15(5):399-405. PubMed ID: 8015420
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the glycolipid receptor specificities of Shiga-like toxin type II and Shiga-like toxin type II variants.
    Samuel JE, Perera LP, Ward S, O'Brien AD, Ginsburg V, Krivan HC.
    Infect Immun; 1990 Mar; 58(3):611-8. PubMed ID: 2155181
    [Abstract] [Full Text] [Related]

  • 16. Construction of recombinant Shiga-like toxin-IIv (SLT-IIv) and its use in monitoring the SLT-IIv antibody status of pigs.
    Franke S, Gunzer F, Wieler LH, Baljer G, Karch H.
    Vet Microbiol; 1995 Jan; 43(1):41-52. PubMed ID: 7716883
    [Abstract] [Full Text] [Related]

  • 17. Comparative toxicity and virulence of Escherichia coli clones expressing variant and chimeric Shiga-like toxin type II operons.
    Paton AW, Bourne AJ, Manning PA, Paton JC.
    Infect Immun; 1995 Jul; 63(7):2450-8. PubMed ID: 7790056
    [Abstract] [Full Text] [Related]

  • 18. Verotoxin production among porcine strains of Escherichia coli and its association with oedema disease.
    Linggood MA, Thompson JM.
    J Med Microbiol; 1987 Dec; 24(4):359-62. PubMed ID: 3320373
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice.
    Melton-Celsa AR, Darnell SC, O'Brien AD.
    Infect Immun; 1996 May; 64(5):1569-76. PubMed ID: 8613362
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.